Gamma-aminobutyric acid for delaying type 1 diabetes mellitus: an update.
- 2024-06-30
- Review
- Annals of pediatric endocrinology & metabolism 29(3)
- Jane Carissa Sutedja
- Bryan Gervais de Liyis
- Made Ratna Saraswati
- PubMed: 38956751
- DOI: 10.6065/apem.2346184.092
- Low evidence
- Children
This review aimed to assess the use of gamma-aminobutyric acid (GABA) to delay the onset of T1DM in children. [...] These findings demonstrate promising results for the use of GABA treatment to delay T1DM, specifically in genetically predisposed children, through immunoregulatory effects and the ability to induce β-cell proliferation.
- Effect
- Beneficial
- Effect size
- Small